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in the biosynthesis of cysteine, in a model organism, Mycobacterium smegmatis.
Mycobacterial assimilation of sulfate begins with its active
transport into the cell, whereupon it is chemically activated by
the enzyme ATP sulfurylase (cysDN) to form activated sulfate
(adenosine 5⬘-phosphosulfate [APS]) (Fig. 1). APS is then
either phosphorylated by APS kinase (cysC) to form the universal sulfuryl group donor 3⬘-phosphoadenosine 5⬘-phosphosulfate (PAPS) or reduced by APS reductase (cysH) to form
sulfite (12, 38). If sulfate assimilates through the sulfuryl transfer branch of the pathway, the sulfuryl group is transferred
from PAPS, via sulfotransferases, to metabolic recipients whose
activities are regulated by the modification. If, on the other hand,
sulfate is drawn into the reductive branch of the pathway by the
action of APS reductase (7, 8), the resulting sulfite is reduced
further, in a six-electron reduction, to sulfide by the enzyme sulfite
reductase (sirA). Sulfide is then incorporated into cysteine by
O-acetyl-L-serine sulfhydrylase (cysK1) (30), and from there the
sulfur atom, originally present in sulfate, flows into a myriad of
reduced-sulfur-containing metabolites.
Nitrite and sulfite reductases have a number of similarities,
including conserved catalytic architectures designed to guide
an essential siroheme cofactor to function as the active center
for a six-electron reduction of substrate to product (12, 13, 22).
These enzymes are sufficiently similar that they will often catalyze the reduction of both sulfite and nitrite (12), suggesting
that sulfur and nitrogen metabolism may be redundant at the
point of sulfite/nitrite reduction and/or in the provision of the
siroheme cofactor. Such redundancy is particularly pertinent in
the case of M. tuberculosis, which must persist amid high levels
of destructive reactive nitrogen species, which it elicits from
activated T cells during infection (40).

The human genome does not encode the sulfur reduction
and cysteine-biosynthetic enzymes found in many pathogenic
bacteria. The species specificity of these enzymes and the essential metabolic nature of sulfur recommend them as potential targets for antimicrobial development. A considerable literature links sulfur metabolism to the pathogenicity and
antibiotic susceptibility of Mycobacterium tuberculosis. Specific
sulfolipids correlate well with the virulence of M. tuberculosis
(16, 17, 19, 20, 26) and are reported to inhibit phagosomelysosome fusion (18), which is critical for the survival of the
bacterium in macrophages (9, 15). More-recent literature calls
into question whether the segregation of sulfolipid across virulent and avirulent strains is a manifestation, rather than a root
cause, of virulence (33, 41), and efforts to trace this lineage
toward its root are under way (11, 27). Mycothiol, the mycobacterial equivalent of glutathione, utilizes a cysteine thiol to
provide the antioxidant protection that the organism needs to
survive, particularly during oxidative stress (35), and lower
mycothiol levels correlate with enhanced susceptibility to antibiotics, including rifampin and isoniazid (32). The cysteinebiosynthetic pathway, a primary means of assimilating sulfur,
has been linked to the survival of the organism during the
chronic phase of infection, the basis of which may lie in its
resistance to reactive oxygen and nitrogen species (39). The
current work explores the reduction of sulfite, an essential step
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Mycobacterium tuberculosis places an enormous burden on the welfare of humanity. Its ability to grow and its
pathogenicity are linked to sulfur metabolism, which is considered a fertile area for the development of
antibiotics, particularly because many of the sulfur acquisition steps in the bacterium are not found in the host.
Sulfite reduction is one such mycobacterium-specific step and is the central focus of this paper. Sulfite
reduction in Mycobacterium smegmatis was investigated using a combination of deletion mutagenesis, metabolite screening, complementation, and enzymology. The initial rate parameters for the purified sulfite reductase from M. tuberculosis were determined under strict anaerobic conditions [kcat ⴝ 1.0 (ⴞ0.1) electron
consumed per second, and Km(SO3ⴚ2) ⴝ 27 (ⴞ1) M], and the enzyme exhibits no detectible turnover of nitrite,
which need not be the case in the sulfite/nitrite reductase family. Deletion of sulfite reductase (sirA, originally
misannotated nirA) reveals that it is essential for growth on sulfate or sulfite as the sole sulfur source and,
further, that the nitrite-reducing activities of the cell are incapable of reducing sulfite at a rate sufficient to
allow growth. Like their nitrite reductase counterparts, sulfite reductases require a siroheme cofactor for
catalysis. Rv2393 (renamed che1) resides in the sulfur reduction operon and is shown for the first time to
encode a ferrochelatase, a catalyst that inserts Fe2ⴙ into siroheme. Deletion of che1 causes cells to grow slowly
on metabolites that require sulfite reductase activity. This slow-growth phenotype was ameliorated by optimizing growth conditions for nitrite assimilation, suggesting that nitrogen and sulfur assimilation overlap at
the point of ferrochelatase synthesis and delivery.
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The genes encoding APS reductase (cysH) and sulfite reductase (sirA) are located in the sulfur reduction operon (see
below) in both M. smegmatis and M. tuberculosis, along with a
third coding region, Rv2393, which encodes a protein of unknown function. In the current study, the sulfite reduction step
in M. smegmatis was explored by deletion mutagenesis, metabolite screening, enzymatic characterization, and complementation.

MATERIALS AND METHODS
Bacterial strains and cultures. The bacterial strains used in this study are
listed in Table 1. The Escherichia coli XL1-Blue and HB101 strains, used for
cloning, and the BL21(DE3) Rosetta pLysS strain, used for expression, were
propagated in Luria-Bertani (LB) broth or on LB agar at 37°C. M. smegmatis
strain mc2155 was grown at 37°C in 7H9 liquid medium (Difco) supplemented
with 0.2% (vol/vol) glycerol, 0.2% glucose, and 0.05% Tween 80 or on Middlebrook 7H10 solid medium supplemented as described above. L-Cysteine was
obtained from the Sigma Chemical Co. The following antibiotics were used at the

TABLE 1. Bacterial strains used in this study
Strain

E. coli strains
XL1-Blue
BL21(DE3) Rosetta pLysS
JR01
302⌬a
cysG pER247 strain
RP7
RP8
HB101
M. smegmatis strains
mc2155
RPMS001
RPMS002
RPMS004
RPMS005

Description

Source or reference

recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 关F⬘ proAB lacIqZ⌬M15 Tn10 (Tetr)兴
F⬘ ompT hsdSB (rB⫺ mB⫺) gal dcm (DE3)pLysSRARE2 (Camr)
Rosetta pLysS carrying plasmid pJR1
E. coli cysG Nirs Lac⫹ CysG⫺
Strain 302⌬a carrying the plasmid pER247 (pACYC184-lacq-Ptac-P. denitrificans cobA)
E. coli cysG pER247 containing plasmid pET23a, M. tuberculosis Rv2393
E. coli cysG pER247 containing plasmid pET23a, M. smegmatis Rv2393
E. coli K-12 F⫺⌬(gpt-proA)62 leuB1 glnV44 ara-14 galK2 lacY1 hsdS20 rpsL20 xyl-5 mtl-1
recA13

Stratagene
Novagen
This work
31
31
This work
This work
4

ept-1
mc2155⌬sirA::hyg sacB
mc2155⌬Rv2393::hyg sacB
RPMS001 carrying plasmid pRP15 (M. smegmatis sirA complementation vector 关Table 2兴)
RPMS002 carrying plasmid pRP16 (M. smegmatis che1 complementation vector 关Table 2兴)

43
This
This
This
This

work
work
work
work
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FIG. 1. Segment of sulfur metabolism in mycobacteria. Red arrows and mnemonic terms identify the activities and genes associated with the
sulfur reduction operon. Dotted arrows highlight steps that are the primary focus of this study. The cysteine feedback inhibition loop is
hypothesized based on similar inhibition in Salmonella enterica serovar Typhimurium (25) and E. coli (21) and complete conservation of the
residues involved in the binding of cysteine (28, 29) across numerous organisms, including M. tuberculosis (29). Ac⫺, without acetyl; CoA, coenzyme
A; AcCoA, acetyl coenzyme A; 3Fd(ox), oxidized ferredoxin; 3Fd(red), reduced ferredoxin; Trx(ox), oxidized thioredoxin; Trx(red), reduced
thioredoxin.
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TABLE 2. Plasmids used in this study

Plasmid

Description
r

Cosmid containing the Hyg -SacB cassette
Shuttle phasmid, TM4ts::pYUB328

pMV261
pMV361
pMS2391
pMS2393
pSKB4-9His-GST
pJR1
pJR2
pRP15
pRP16
pET23a
pRP17
pRP18
pKK E. coli cysG

Kanr ColE1 oriM aph Phsp60⬘
Integrative vector Hygr
Recombinant cosmid derived from p0004S containing the M. smegmatis sirA AES
Recombinant cosmid derived from p0004S containing the M. smegmatis Rv2393 AES
Derived from pGEX-6P-1; contains an N-terminal His tag upstream of a GST tag
pSKB4-9His-GST carrying the M. tuberculosis sirA gene
pJR1 with E. coli cysG cloned downstream of sirA
pMV261 carrying the M. smegmatis sirA gene
pMV261 carrying the M. smegmatis Rv2393 gene
Cloning vector containing an N-terminal His tag
pET23a carrying M. tuberculosis Rv2393
pET23a carrying M. smegmatis Rv2393
pKK223.3, an overexpression vector derived from pBR322 with the tac promoter,
carrying E. coli cysG

concentrations indicated: ampicillin (100 g/ml) (Fisherbiotech), kanamycin A
(25 g/ml) (Sigma), hygromycin B (50 g/ml with E. coli and 50 to 150 g/ml with
M. smegmatis) (Roche).
To obtain the growth curves associated with Fig. 4, M. smegmatis was grown to
late exponential phase at 37°C; washed six to eight times in M9 minimal salts
without a sulfur source (Na2HPO4 [42 mM], KH2PO4 [24 mM], NaCl [9.0 mM],
NH4Cl [19 mM], glucose [0.5%, wt/vol], Tween 80 [0.05%, vol/vol]); suspended
in prewarmed M9 medium supplemented with a specific source of sulfur, SO4⫺2
(1.0 mM), Na2S (1.0 mM), Na2SO3 (1.0 mM), or cysteine (200 M); and cultured
further by shaking at 37°C. Bacterial growth was monitored at 600 nm. To
normalize the wild-type and mutant genetic backgrounds in the strains used in
Fig. 4C, the wild-type strain was transformed with pMV361, which codes for Hygr
and integrates into the genome (44), and pMV261, which confers kanamycin
resistance. The mutant strains associated with Fig. 4C were transformed using
derivatives of pMV261 that contained either the wild-type sirA gene (pRP15) or
Rv2393 (pRP16).
The cell growth studies presented in Fig. 6 were accomplished by shaking cells
overnight at 37°C in the following M9 minimal medium: NaNO3 (20 mM),
cysteine (200 M), Na2HPO4 (42 mM), KH2PO4 (24 mM), NaCl (9.0 mM),
glucose (0.5%, wt/vol), Tween 80 (0.05%, vol/vol). The cells were then washed as
described above in prewarmed M9 medium lacking a sulfur source. The growth
studies were initiated by suspending the washed cells in prewarmed M9 medium
with either cysteine or sulfate.
Ferrochelatase complementation. To assess whether Rv2393 encodes a ferrochelatase, an E. coli cysteine auxotroph that requires ferrochelatase function for
growth on SO4⫺2 (strain 302⌬a, a cysG deletion strain containing pER247, a P15

2
J. Kriakov and W. R.
Jacobs, unpublished
44
44
This study
This study
1
This study
This study
This study
This study
Novagen
This study
This study
31

origin plasmid that expresses uroporphyrinogen III methyltransferase) was transformed with ColE1 origin plasmids that express Rv2393 either from M. tuberculosis(pRP17) or M. smegmatis(pRP18) and then tested for the ability to grow on
SO4⫺2 as a sole source of sulfur. Conversion to prototrophy was assessed on
minimal agar containing either SO4⫺2 or cysteine as the sulfur source. Minimal
agar contained Na2HPO4 (42 mM), KH2PO4 (24 mM), NaCl (9.0 mM), NH4Cl
(19 mM), agar (15 g/liter), CaCl2 (0.10 mM), MgCl2 (1.0 mM), glucose (2.0%),
and either MgSO4 (2.0 mM) or cysteine (280 M). 302⌬a carrying pKK (which
expresses E. coli CysG) was used as the positive control for growth; the negativegrowth-control strain was 302⌬a, which carries pER247 and pET23a (the empty
Rv2393 expression vector). All plates were incubated at 37°C for 24 to 48 h.
DNA manipulation. Restriction enzymes (REs) were purchased from New
England Biolabs, and digestions were performed according to the manufacturer’s
recommendations. The purification of DNA from agarose gels and the isolation
of plasmid DNA were done using QIAquick gel extraction and QIAprep spin
miniprep kits (QIAGEN) according to the manufacturer’s protocols. Isolation of
M. tuberculosis and M. smegmatis chromosomal DNA was carried out as described previously (5). Standard heat shock protocols were used for the transformation of E. coli strains (34).
Plasmid construction. All of the plasmids and primers used in this study are
listed in Tables 2 and 3, respectively.
sirA expression vector. The expression of catalytically competent SirA requires
the coexpression of CysG, which produces the quantities of the siroheme cofactor needed for stoichiometric incorporation into SirA. The construction of the
coexpression plasmid pJR2 was accomplished in two steps. First, a 1.7-kb fragment containing sirA was PCR amplified from M. tuberculosis genomic DNA

TABLE 3. Primers used in this study
Primera

Sequence (5⬘–3⬘)

TBsirA F
TBsirA R
colicysG F
colicysG R
smegsirA F
smegsirA R
smegRv2393 F
smegRv2393 R
1
1⬘
2
2⬘
3
3⬘
4
4⬘

GGAATTCCATATGTCCGCGAAGGAGAACCCC
AAGGAAAAAAGCGGCCGCTCATCGCAGGTCGTCCTCCTCGGCCCGGAT
TTTGCGGCCGCAAACGGCTGCCGGTTAATTACTAAGGGGTTTTTAC
GGCCTAGGTTAATGGTTGGAGAACCAGTTCAGTTTATC
TACAGCTGATGCTCGAAGACGAGTACTTCAT
CCCAAGCTTTCACGTTGCCTACCTCAAATCCGCTTCGTC
CGCAGCTGGTGACGCTCGTCCTGACCGCACAC
CCCAAGCTTTCAGCGCATGGCCCTGGCCCGTGCACT
TTTTTTTTCCATAAATTGGGTAGATGCCGAAGGGCCGGCCCGGTGTGGG
TTTTTTTTCCATTTCTTGGGCCGACGGCGTCGAGGCGCTTCCAGATCTC
TTTTTTTTCCATAGATTGGGGCCCCGAGGAGGGTTTCCAGGTGCATCTG
TTTTTTTTCCATCTTTTGGGCCCGCATTCGGTCTTGGACAGCCCGGCCC
TTTTTTTTCCATAAATTGGGTGCGCAACTTCGTGAAACAACGCGAGGAC
TTTTTTTTCCATTTCTTGGAGATTCGGTTCGTTCTGCTCACAGAAC
TTTTTTTTCCATAGATTGGTCGACCGCTACGAAGAGGCGATCGAGG
TTTTTTTTCCATCTTTTGGTATCGGTTTCGTGTTCCAGCACTATGCGGC

a

F and R refer to forward and reverse primers.

Amplified sequence

M. tuberculosis sirA
E. coli cysG
M. smegmatis sirA
M. smegmatis Rv2393
3⬘-end-flanking region of
M. smegmatis sirA
5⬘-end-flanking region of
M. smegmatis sirA
3⬘-end-flanking region of
M. smegmatis Rv2393
5⬘-end-flanking region of
M. smegmatis Rv2393

Downloaded from http://jb.asm.org/ on November 19, 2018 by guest

p0004S
phAE159

Reference or source
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TABLE 4. Primary sequence similarity of SirA from M. smegmatis
and M. tuberculosisa
Enzyme

Coding
region

Identity
(%)

Similarity
(%)

Sulfite reductase
APS reductase
Hypothetical protein

sirA
cysH
Rv2393

82
70
58

89
78
70

a
CLUSTAL W comparison metrics for homologous proteins encoded by the
M. smegmatis and M. tuberculosis sulfur reduction operons (45).

Expression and purification of M. tuberculosis SirA. LB medium was inoculated with an overnight culture of JR01 at an A600 of 0.01, and the cells were
grown at 37°C until the optical density at 600 nm reached ⬃0.7, at which point
SirA expression was induced by adding isopropyl-␤-D-thiogalactopyranoside
(IPTG) to a final concentration of 0.80 mM. The incubation temperature was
then shifted to 17°C, and cells were harvested by centrifugation 17 h later. The
cell pellet was suspended in 4.2 ml/g cell paste of lysis buffer (KPO4 [50 mM, pH
8.0], KCl [0.4 M], phenylmethylsulfonyl fluoride [290 M], pepstatin A [1.5 M],
lysozyme [0.10 mg/ml]), and the solution was stirred for 1 h at 4°C prior to
sonication on ice (Branson sonifier). Cellular debris was removed by centrifugation (20 min at 31,000 ⫻ g), and the supernatant was loaded onto a 5-mlchelating-Sepharose fast-flow column charged with Ni2⫹ and equilibrated with
buffer A (KPO4 [50 mM, pH 7.3], KCl [0.4 M]). The column was washed with 10
bed volumes of buffer B (KPO4 [50 mM, pH 7.3], KCl [0.4 M], imidazole [10
mM]). The His–glutathione S-transferase (GST)-tagged fusion protein was then
eluted from the Ni2⫹-chelated Sepharose column with 10 bed volumes of buffer
C (KPO4 [50 mM, pH 7.3], KCl [0.4 M], imidazole [250 mM], KCl [0.40 M]). The
N-terminal His–GST tag was removed by digestion with PreScission protease
(GE Healthcare) during overnight dialysis against HEPES-K⫹ (25 mM, pH 7.5),
KCl (100 mM), glycerol (5%), and ␤-mercaptoethanol (5.0 mM) at 4°C. To
remove the tag and any uncut fusion protein, the dialyzed proteolysate was
passed back over the Ni2⫹ affinity column and washed extensively with buffer B
to remove the SirA, which exhibited an affinity for the resin. Typically, 10 mg of
protein (⬎95% pure, as judged by eye from Coomassie blue-stained sodium
dodecyl sulfate-polyacrylamide gels) was obtained per liter of culture.
Sulfite reductase assay. M. tuberculosis SirA was assayed for sulfite and nitrite
reductase activity under anaerobic conditions activity using methyl viologen
(MV) as an electron donor, which was reduced with Zn metal immediately prior
to use (42). The assay mix contained O-acetyl-serine (5.0 mM), sodium sulfite (13
M), reduced MV (250 M), O-acetyl-serine sulfhydrylase (1.5 M), SirA (1.3
M), and 50 mM HEPES-K⫹ (pH 8.0) (25 ⫾ 3°C). The assay was carried out
under anaerobic conditions; argon gas scrubbed with reduced MV and ascorbic
acid was used to degas all buffers and to maintain all samples under positive
pressure in a vacuum manifold. A custom optical cuvette that allowed maintenance of positive pressure while the mixture was stirred was used to optically
monitor reactions. The assay was initiated by the addition of the sodium salts of
sulfite or nitrite. The enzymatic consumption of either sulfite or nitrite was
monitored by following the decrease in absorbance at 684 nm (ε ⫽ 4.8 ⫻ 103 M⫺1
cm⫺1) caused by the oxidation of MV (24).

RESULTS
Sulfur reduction operon—an overview. The M. smegmatis
and M. tuberculosis sulfur reduction operons are quite similar
(Fig. 1A; Table 4). At their 5⬘ termini, they begin with sirA
(sulfite reductase) followed by cysH (APS reductase) and
Rv2393 (a hypothetical protein). In both organisms, each of
the three coding regions appear to be translationally coupled
(i.e., the stop codon of the 5⬘ gene overlaps the start codon of
its downstream partner). The homologous coding regions in
the two strains are similar in both length and sequence (Table
4; Fig. 2) (45). The metabolically linked, sulfate transport operons, which include an ABC transporter (encoded by cysTWA)
and a sulfate binding protein (encoded by subI), are antipar-

FIG. 2. Sulfur reduction operons of M. smegmatis and M. tuberculosis. (A) Schematic representation of the M. smegmatis (M. smeg) and
M. tuberculosis (M. tb) sirA operons. The double hatch mark in the M.
tuberculosis diagram indicates a 5-kb intergenic region between the
operons.
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using primers TBsirA F and TBsirA R and inserted into the NdeI and NotI sites
of pSKB4 (1), yielding pJR1. In the second step, E. coli cysG was PCR amplified
(primers colicysG F and colicysG R) and cloned into pJR1 linearized with NotI
and BsaAI. The resulting plasmid, pJR2, was used to transform the E. coli
BL21(DE3) Rosetta pLysS strain for expression and purification (see below).
This strain was named JR01.
Complementation plasmids. M. smegmatis sirA and Rv2393 were PCR amplified from genomic DNA using the primer pairs smegsirA F/smegsirA R and
smegRv2393 F/smegRv2393 R, respectively. In both cases, the forward and
reverse primers introduced PvuII and HindIII restriction sites, respectively,
which were used to subclone the PCR products into pMV261 (cleaved with the
same enzymes), producing plasmids pRP15 (sirA) and pRP16 (Rv2393).
pMV261 contains the mycobacterial hsp60 promoter, which facilitates constitutive expression of M. smegmatis SirA and M. smegmatis Rv2393 (44). All constructs were sequenced (AECOM DNA sequencing facility) to confirm the
fidelity of the clones.
Construction of M. smegmatis gene deletion mutants. The M. smegmatis gene
deletion mutants were constructed in three stages: recombinant cosmids containing the DNA sequences needed for allelic exchange (allelic-exchange substrates [AESs]) were prepared, high-titer mycobacteriophages needed to isolate
genomic deletion events (which occur at low levels) were obtained, and mycobacterial DNA was transduced and selected for allelic exchange. The protocols
used to create mycobacterial gene deletion mutants have been described previously (5).
Cosmid construction. DNA flanking the 5⬘ and 3⬘ regions of sirA was PCR
amplified, using primer pairs 1/1⬘ and 2/2⬘ (see Fig. 3A and Table 3). The
flanking regions were subcloned directionally, using the Van911 RE, on either
side of the hygromycin resistance-sacB gene cassette found in cosmid p0004S.
The resulting recombinant cosmid, pMS2391, contained the AES needed to
construct the bacteriophage. Using an identical protocol, primer pairs 3/3⬘ and
4/4⬘ were used to generate pMS2393, which contains the Rv2393 AES.
Mycobacteriophage construction. The AES cosmids and purified phagemid
DNA (phAE159) were digested separately with PacI, ligated together, and in
vitro packaged (using the GIGApackIII Gold packaging extract [Stratagene]) to
produce the transducing  bacteriophage. E. coli HB101 was then transduced
with the phage, and transductants were selected on medium containing hygromycin (150 g/ml). Phasmid construction was confirmed by PacI digestion prior
to electroporation of the phasmid DNA into M. smegmatis. Electroporated cells
were plated on 7H10 medium and incubated at the permissive temperature,
30°C, for 3 days. All transducing phages were plaque purified, and high-titer
phage lysate (1010 to 1011 PFU/ml) was prepared. M. smegmatis was then transduced by mixing late-log-phase cells with phage lysate (1:1, vol/vol) overnight at
37°C. Transductants were plated onto 7H10 medium plates containing hygromycin (75 g/ml) and cysteine (40 g/ml) and incubated at the nonpermissive
temperature, 37°C, for 5 days. M. smegmatis deletion mutants were screened by
Southern blot analysis (see below).
Southern blotting. Five micrograms of M. smegmatis genomic DNA was digested completely with either the BanII or the MscI RE and separated by
electrophoresis on a 0.7% DNA agarose gel. The gel was immersed in 0.25 M
HCl for 5 min, rinsed in H2O, and soaked in 0.40 M NaOH for 10 min. DNA
fragments were transferred onto a nylon membrane (Amersham) overnight by
the capillary action of a 0.40 M NaOH transfer solution. The membrane was
cross-linked (Stratagene) to allow immobilization of DNA fragments on the
membrane and then incubated for 10 min in 5 ml of Rapid-hyb buffer (Amersham). Changes in DNA fragment size caused by the deletions were probed using
32
P-labeled probes that spanned the 5⬘ end of sirA and 3⬘ end of Rv2393. The
probes were generated by PCR using the 1/1⬘ and 4/4⬘ primer pairs (Table 3 and
see Fig. 3A).
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allel to the sulfur reduction operon in both cases but differ in
that they are separated by ⬃5 kb in M. tuberculosis and only 10
bp in M. smegmatis.
Construction of sirA and Rv2393 deletion mutants. To begin
to assess the role of sirA and Rv2393 in vivo, each gene in M.
smegmatis was deleted using allelic exchange. First, allelicexchange cosmids containing a selectable gene cassette (␥␦ res
hyg sacB res ␥␦) flanked by ⬃900-bp regions of DNA that
spanned the 3⬘ and 5⬘ edges of sirA or Rv2393 were constructed
(see Materials and Methods). The AESs were then incorporated
into the conditionally replicating phasmid phAE159, in vitro
packaged into  phage heads, and transduced into E. coli
HB101. Recombinant shuttle cosmids were purified from Hygr
E. coli transductants and converted into mycobacteriophagepackaged DNA molecules by transfecting them into M. smegmatis cells. These cells were plated for phage plaques at the
permissive temperature of 30°C. High-titer transducing lysates
were obtained by propagation of the mycobacteriophage in M.
smegmatis. The lysates were used to transduce M. smegmatis at
the nonpermissive temperature (37°C) and plated on selective
medium. Restriction of phage replication results in a doublecrossover event between the homologous DNA arms flanking
the disrupted gene (5). Fifteen transductants were obtained in
the case of sirA and six in the case of Rv2393. Six isolates from
each set were tested by Southern blot analysis, all of which had
undergone the expected allelic replacement. A single representative from each set is shown in Fig. 3B. The observed shifts
in DNA fragment size caused by insertion of the Hygr-SacB
gene cassette into the genomic copies of sirA and Rv2393 are

in excellent agreement with the expected values—1.4 and 1.3
kb, respectively.
sirA is essential for growth in minimal media. Upon entering the macrophage, M. tuberculosis maintains the expression
of SirA, a sulfite reductase that catalyzes the six-electron reduction of sulfite (37). Frequently, both sulfite and nitrite can
be reduced by either nitrite or sulfite reductases, which are
classified on the basis of their substrate preference (12). Thus,
a strain lacking sirA might obtain the sulfide needed for cysteine biosynthesis from the reduction of sulfite by other reductases, which would render sirA nonessential and perhaps diminish its efficacy as an antimicrobial target. To establish
whether the organism depends essentially entirely on SirA for
the provision of sulfide, the M. smegmatis sirA deletion mutant
was tested for its ability to grow, relative to the wild type, on
sulfur metabolites that straddle either side of the point of
action of sirA in the cysteine-biosynthetic pathway. When the
mutant and wild type were fed downstream metabolites (i.e.,
S⫺2 or cysteine), their growth rates were virtually indistinguishable; however, when fed an upstream metabolite (SO4⫺2 or
SO3⫺2), the mutant showed no detectible growth over a 50-h
incubation, while the wild type grew with a doubling time of 7.1
(⫾0.4) h (Fig. 4A). sirA is clearly essential for growth on SO4⫺2
or SO3⫺2 and central to the sulfur-reducing metabolism of the
organism.
SirA—the enzyme. The kinetic parameters and efficiency of
the enzyme toward sulfite reduction have not yet been determined. For this reason, the enzyme from M. tuberculosis was
expressed in E. coli and purified to homogeneity (see Materials
and Methods), and the kinetic constants were determined.
Obtaining pure SirA with the expected levels of siroheme cofactor (22) required coexpression of E. coli CysG, a trifunctional protein that catalyzes the last three steps in siroheme
biosynthesis (see Materials and Methods). The reduction reaction was monitored continuously, under anaerobic conditions, by following the change in absorbance at 684 nm associated with the oxidation of the electron donor, MV (24).
Sulfide produced by SirA was removed rapidly by serine sulfhydrylase (from E. coli), which converts O-acetyl-L-serine and
sulfide to cysteine (46). The removal of the product ensures
that product inhibition will not contribute significantly to the
reaction, which simplifies extracting kinetic constants from the
reaction progress curve (1). Under such conditions, slopes
taken over sufficiently small regions (⬃3%) of the progress
curve provide initial rate measurements over an essentially
continuously varying range of substrate concentrations. The
double-reciprocal plot of the SirA-catalyzed reduction of sulfite is shown in Fig. 5. The kinetic constants obtained by fitting
the data are as follows: Km(SO3⫺2) was equal to 27 (⫾1) M, the
kcat was equal to 0.17 (⫾0.01) electron consumed s⫺1 (sulfite
reduced to sulfide) or 1.0 electron consumed s⫺1, and the
catalytic efficiency (kcat/Km) was equal to 3.7 ⫻ 104/M⫺1 s⫺1. It
should be noted that, consistently with previous work (38), no
enzymatic turnover was observed when sulfite was replaced by
nitrite at concentrations as high as 3.0 mM.
Growth phenotype of the Rv2393 deletion mutant. Rv2393 is
situated at the C terminus of the sulfur reduction operon. This
locale suggests that Rv2393, whose function is unknown, may
be important for cysteine biosynthesis. To explore the ways in
which Rv2939 might function in the cysteine-biosynthetic path-
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FIG. 3. Insertion of a hygromycin resistance cassette into sirA and
Rv2393 in M. smegmatis mc2155. (A) Primer sets used for the construction of Southern blot probes and AESs. (B) Southern blot of
genomic DNAs from wild-type (wt) and ⌬sirA strains. BanII-digested
genomic DNA was probed using a PCR fragment generated using
primers 1 and 1⬘. The blot revealed that insertion of the resistance
cassette caused the expected shift from 1.1 to 2.5 kb. (C) Southern blot
of genomic DNAs from the wild-type (wt) and ⌬Rv2393 strains. MscIdigested genomic DNA was probed using a PCR fragment generated
using primers 4 and 4⬘. Insertion of the resistance cassette resulted in
the expected shift from 6.3 to 5.0 kb.
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FIG. 4. Growth of M. smegmatis mutants on various sulfur nutrients. (A) Growth of the ⌬sirA mutant on minimal media containing
cysteine (䡺), sulfide (䉬), sulfite (E), or sulfate (F) as the sole sulfur
source. Generation times for growth on cysteine and sulfide were 7.5
and 6.7 h, respectively; no growth was observed in media containing
sulfite or sulfate. (B) Growth of the ⌬Rv2393 mutant on the same
sulfur sources as those mentioned for panel A. The generation time for
the mutant was 10 h when the medium contained cysteine or sulfide.
Both cells fed sulfate and cells fed sulfite exhibited steady-state growth
with a generation time of 19 h. (C) To demonstrate that the growth
effects of the deletions were due solely to a lack of expression of the
intended coding regions, the growth on sulfate of the deletion strains
complemented with plasmids that express the wild-type gene was compared to that of the wild-type strain containing an empty vector. The
doubling times of the three strains were extremely similar: for the wild
type (E), 8.8 h; for the ⌬sirA strain compared with the sirA strain
(nirA:comp sirA) (䡺), 8.6 h; and for the ⌬Rv2393 strain compared with
the Rv2393 strain (⌬rv2939:comp rv2393) (䉬), 8.5 h. Growth protocols
are described in Materials and Methods. Each data point represents
the average of results from three experiments; single standard deviation units (not shown) are comparable to the diameters of the symbols
representing the averaged values. OD600, optical density at 600 nm.

way of M. smegmatis, an Rv2393 deletion strain was constructed (see Materials and Methods). The deletion removes
the entire gene with the exception of short, 140- and 53-nucleotide stretches of sequence at the 5⬘ and 3⬘ edges of the coding
region, respectively (Fig. 3A). Growth of the deletion strain on
sulfide or cysteine is indistinguishable from that of the wild
type (Fig. 4B and C), suggesting that Rv2393 acts upstream of
the enzymes that incorporate sulfide into cysteine (O-acetylserine sulfhydrylase [cysK1] and serine transacetylase [cysE]).
In contrast, the doubling time of the mutant on sulfite or
sulfate was approximately twofold slower than that of the wild

type (Fig. 4B and C). Thus, the point of action of Rv2393
coincides with that of SirA: the reduction of sulfite.
The primary structure of Rv2393 clusters with an orthologous
group of proteins from ancient phylogenies (COG2381.1), many
of which are type II chelatases—catalysts that insert divalent
cations (Co2⫹, Fe2⫹, Mg2⫹, or Ni2⫹) into modified tetrapyrroles to produce redox-sensitive cofactors, including chlorophylls, vitamin B12, heme, coenzyme F430, and siroheme (6).
Sulfite and nitrite reductases, which are often essential for the
assimilation of sulfur and nitrogen, require siroheme to accomplish their redox chemistry. The linking of Rv2393 to the chelatase family and to sulfite reductase function provides a rationale for the colocalization of sirA and Rv2393 and the
common metabolic point of action of the proteins that they
encode, which is that Rv2393 is the ferrochelatase that inserts
Fe2⫹ into sirohydrochlorin to produce the siroheme cofactor
that is necessary for SirA function.
To test the hypothesis that Rv2393 is, in fact, a ferrochelatase, plasmid-borne Rv2393 was used to complement an E.
coli ⌬cysG mutant (302⌬a) (Table 1), in which ferrochelatase
function is deleted. The genome of the mutant lacks cysG,
which encodes siroheme synthase, a trifunctional protein that
catalyzes the last three steps in siroheme biosynthesis: (i)
methylation of uroporphyrinogen III (at C-2 and C-7) to produce dihydrosirohydrochlorin; (ii) oxidation of dihydrosirohydrochlorin to produce sirohydrochlorin; and (iii) insertion of
Fe2⫹ into sirohydrochlorin to produce siroheme (31). The cysteine-biosynthetic pathway is disrupted in cysG deletion strains
at the point of insertion of iron into sirohydrochlorin. The
cysteine auxotrophy that results from the inability to produce
siroheme provides a nutrient-based selection for methyltransferase and/or chelatase function. It should be noted that the
dehydrogenase function needed by these strains is provided by
endogenous activity (47); thus, selecting for ferrochelatase
function exclusively requires restoration of the methyltransferase activity in 302⌬a, which is accomplished by transforma-
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FIG. 5. Initial rate determination of the Michaelis constants for the
SirA-catalyzed reduction of sulfite. Sulfite reduction was monitored
continuously (under stringent, anaerobic conditions) via the change in
absorbance at 684 nm associated with the oxidation of the electron
donor, MV (see Materials and Methods). The assay conditions were as
follows: sulfite (13 M), reduced MV (250 M), O-acetyl-L-serine (30
M), SirA (1.3 M), O-acetyl-L-serine sulfhydrylase (1.2 M), and
HEPES-K⫹ (50 mM, pH 8.0) (25 ⫾ 3°C). The reaction rate is given in
terms of sulfite reduced per unit time (M/s⫺1). The reduction of one
equivalent of sulfite requires the oxidation of six equivalents of MV.
v, initial velocity.
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FIG. 6. Growth of M. smegmatis mutants on nitrate. (A) Growth of
the ⌬sirA mutant on minimal medium containing nitrate as the sole
nitrogen source and either cysteine (E) or sulfate (F) as the sole sulfur
source. The generation time for growth on cysteine was 7.1 h, as no
growth was observed in medium containing sulfate. (B) Growth of the
⌬che1 mutant on the same nitrogen and sulfur sources as described for
panel A. Generation times for growth on cysteine or sulfate were
virtually identical, 7.3 h. Growth protocols are described in Materials
and Methods. Each data point represents the average of results from
three experiments; single standard deviation units (not shown) are
comparable to the diameters of the symbols representing the averaged
values. OD600, optical density at 600 nm.

differences in the substrate specificities of the enzymes that catalyze these reactions.
Unlike the ⌬sirA mutation, which causes a no-growth phenotype, the ⌬che1 mutation results in slow growth of the organism on sulfate or sulfite. Thus, the orthogonality seen in the
sulfite reduction step clearly does not extend to the siroheme
cofactor, which can be provided to SirA from alternative metabolic sources. Amelioration of slow growth by plasmid-born
Che1 suggests that the endogenous siroheme pool(s) is in some
way insufficient to achieve the levels of SirA activity needed for
normal growth. Because nitrite reductase requires siroheme, it
is plausible that the growth of the organism on nitrite, compared to that on ammonia, will up-regulate the cellular levels
of siroheme; if so, the growth rate of the⌬che1 mutant, when
grown on sulfate or sulfite, will increase when the nitrogen
source is switched from ammonia to nitrate. This is precisely
what was observed (Fig. 6B). Clearly, the perturbation of nitrogen metabolism caused by the ammonia-to-nitrate substitution has impacted sulfur metabolism at the intersection of
sulfite reduction and ferrochelatase function.
DISCUSSION
The structure of SirA was determined recently, and the
enzyme was shown to reduce sulfite (at a single sulfite concen-
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tion with pER247, a P15 origin plasmid that expresses the
Pseudomonas denitrificans CobA protein, a uroporphyrinogen
III methyltransferase that does not exhibit chelatase function
(3, 14). The 302⌬a strain harboring pER247 and pET23a with
or without the Rv2393 coding region were plated onto minimal
medium plates containing either sulfate or cysteine as the sole
source of sulfur (see “Ferrochelatase complementation” in
Materials and Methods) and incubated at 37°C for 24 to 48 h.
The methyltransferase-competent strain (302⌬a/pER247/pET23a)
showed no detectible growth on sulfate as a sole source of
sulfur. However, when transformed with a pET23A plasmid
containing Rv2393, either from M. tuberculosis or M. smegmatis, the growth on the sulfate-containing plates was comparable to that of the cysG-complemented strain. The observed
Rv2393-dependent transformation of the strain to cysteine
prototrophy strongly supports the idea that Rv2393 encodes a
ferrochelatase that is capable of inserting Fe2⫹ into sirohydrochlorin to produce siroheme. Based on these findings, we have
named Rv2393 che1 to indicate both its chelatase function and
that it does not appear to be the only chelatase in the M.
tuberculosis genome.
Metabolic complementarity in sulfite and nitrite reduction.
Assimilatory nitrite and sulfite reductases, like those found in
M. smegmatis and M. tuberculosis, share similar catalytic strategies, molecular architectures, and substrate specificities.
These enzymes are named on the basis of their relative catalytic efficiencies (Vmax/Km) for sulfite versus nitrite, and interestingly, despite a greater overall efficiency toward sulfite,
sulfite reductases often turn over faster with nitrite [i.e.,
Vmax(NO2⫺1) ⬎ Vmax(SO3⫺2)] (12). Thus, the inability of the ⌬sirA
strain to grow on sulfite could reflect the inefficiency of the
mycobacterial nitrite reductase toward sulfite, which has not
been measured, and/or the level at which the enzyme is expressed in the organism when grown on ammonia (as was the
case in the present study).
Given that sulfite reductase (SirA) is remarkably inefficient
toward nitrite (see above), it appears from the M. smegmatis
genome that nitrite reductase (nirBD) is the organism’s sole
means of obtaining ammonia from either nitrate or nitrite (10,
23). Ammonia is required for the biosynthesis of amino acids,
and from there, nitrogen is drawn into the urea cycle, glutamate metabolism, pyrimidine biosynthesis, and ultimately
every nitrogen-containing compound in the cell (23). To assess
the ability of nitrite reductase to reduce sulfite in vivo, the
growth of the ⌬sirA mutant on sulfate was assessed in a medium selected to optimize the expression of nitrite reductase
for the assimilation of nitrogen, M9 medium in which nitrate
was substituted for ammonia at an equivalent concentration,
20 mM. Under this condition, all assimilated nitrogen must
pass either through nitrite reductase or through other, as-yetunidentified, reductases in the cell. The substitution of nitrate
for ammonia did not result in detectible growth of the organism on sulfate over a 70-h period at 37°C; however, replacement of sulfate by cysteine produced normal growth with nitrite (Fig. 6A). Clearly, the nitrite reductase activity of the cell
is sufficient to allow normal growth on metabolites that lie
downstream of the point of action of SirA. Thus, nitrogen and
sulfur metabolism are well isolated at the point of nitrite and
sulfite reduction by what may ultimately prove to be pronounced
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tration, 5.0 mM) under oxygen-depleting conditions (excess
sodium dithionite) (38). In the current work, the initial rate of
sulfite reduction was studied under strict anaerobic conditions
as a function of sulfite concentration, which yielded kinetic
constants for the enzyme [kcat ⫽ 0.17 (⫾0.1) electron consumed s⫺1 (sulfite reduced) and Km(SO3⫺2) ⫽ 27 (⫾1) M] that
are in line with previously published values for sulfite reductases from other organisms (12, 24). The value of kcat/Km,
3.4 ⫻ 104/M⫺1 s⫺1, indicates that SirA catalyzes SO3⫺2 reduction with modest efficiency, and the inability to detect the
SirA-catalyzed reduction of nitrite at concentrations as high as
3.0 mM reveals that the efficiency of the enzyme toward NO2⫺1
is extremely low and suggests that this reaction is not likely to
be physiologically relevant.
High-density transposon insertion mutagenesis in combination with microarray mapping of the M. tuberculosis genome
has indicated that sirA is important for optimal growth of the
organism on minimal medium containing sulfate as a sole
source of sulfur (36). sirA was deleted in the present work and
shown to be essential for the growth of M. smegmatis on sulfate
or sulfite, regardless of whether nitrate or ammonia was used
as a nitrogen source. These facts are of value not only for their
contribution to the genetic and biochemical fundamentals of
sulfur reduction in M. smegmatis and related organisms but
also for what they reveal about the orthogonality of the sulfur
and nitrogen-reducing pathways in these species. On this note,
it is interesting that it may be possible to assess, and therefore
more accurately annotate, the sulfite-versus-nitrite substrate
preferences of ferredoxin-dependent reductases based on primary sequence (38).
The common metabolic point of action of Rv2393 and SirA,
the siroheme requirement for SirA function, and the ability of
Rv2393 to complement an E. coli ferrochelatase mutant argue
strongly that Rv2393, a protein with previously unidentified
function, is a ferrochelatase, which we have named che1. The
fact that the slow-growth phenotype of the ⌬che1 mutant is
rescued by plasmid-encoded Che1 or by growth on nitrate
supports the idea that the organism’s growth rate is limited by
siroheme access. While nitrogen and sulfur metabolism are
well isolated by what appear to be nonoverlapping substrate
specificities of the nitrite and sulfite reductases, these pathways
do overlap at the level of siroheme production. It is interesting
to note that a second CbiX-like open reading frame (Rv0259c)
is found quite near the genes that encode nitrite reductase in
M. smegmatis. Perhaps the siroheme pool(s) in the mutant
grown on rate-limiting sulfur metabolites is simply too small to
satisfy the metabolic demands placed on it; alternatively, access of SirA to the pool(s) could be limited by intrinsic specificities that bias delivery of the metalated porphyrin to particular recipients. It is exciting to consider the possibility that the
⌬che1 strain, whose growth rate is limited by sulfite reduction,
presents us with the opportunity to establish a linkage between
sulfite reduction and metabolic sources of siroheme.
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